AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+5.69%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.88B
AUM Growth
+$183M
(+4.9%)
Cap. Flow
+$10.3M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
90.38%
Holding
98
New
16
Increased
18
Reduced
14
Closed
4
Top Buys
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$15.9M |
| 2 |
MetLife
MET
|
$10.6M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$10.1M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$7.69M |
| 5 |
Neurocrine Biosciences
NBIX
|
$7.58M |
Top Sells
| 1 |
Incyte
INCY
|
$43.4M |
| 2 |
BLUE
bluebird bio
BLUE
|
$15.7M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.1M |
| 4 |
CELG
Celgene Corp
CELG
|
$11.6M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$10.3M |
Sector Composition
| 1 | Consumer Staples | 52.04% |
| 2 | Healthcare | 33.12% |
| 3 | Consumer Discretionary | 12.51% |
| 4 | Financials | 0.85% |
| 5 | Industrials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVXS
26
DELISTED
AveXis, Inc. Common Stock
AVXS
| $9.12M | 0.2% |
120,000
-30,000
| -20% | -$2.28M |
|
|
AGEN
27
Agenus
AGEN
$136M
| $8.29M | 0.18% |
112,090
+10,190
| +10% | +$754K |
|
|
RXDX
28
DELISTED
Ignyta, Inc.
RXDX
| $8.06M | 0.18% |
937,000
+87,000
| +10% | +$748K |
|
|
TSRO
29
DELISTED
TESARO, Inc.
TSRO
| $7.69M | 0.17% |
+50,000
| New | +$7.69M |
|
30
e.l.f. Beauty
ELF
$7.38B
| $7.2M | 0.16% |
250,000
+100,000
| +67% | +$2.88M |
|
31
Seres Therapeutics
MCRB
$162M
| $6.76M | 0.15% |
30,000
-5,000
| -14% | -$1.13M |
|
|
ARRY
32
DELISTED
Array Biopharma Inc
ARRY
| $6.71M | 0.15% |
750,000
-500,000
| -40% | -$4.47M |
|
|
JNCE
33
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $6.6M | 0.15% |
+300,000
| New | +$6.6M |
|
|
GBT
34
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $6.45M | 0.14% |
175,000
-71,054
| -29% | -$2.62M |
|
|
ARAV
35
DELISTED
Aravive, Inc. Common Stock
ARAV
| $6.41M | 0.14% |
+50,000
| New | +$6.41M |
|
|
ALDR
36
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $6.24M | 0.14% |
+300,000
| New | +$6.24M |
|
37
Sarepta Therapeutics
SRPT
$1.98B
| $5.92M | 0.13% |
200,000
| – | – |
|
38
MacroGenics
MGNX
$121M
| $5.58M | 0.12% |
300,000
+100,000
| +50% | +$1.86M |
|
39
AC Immune
ACIU
$227M
| $5.18M | 0.12% |
500,000
+250,000
| +100% | +$2.59M |
|
|
MDCO
40
DELISTED
Medicines Co
MDCO
| $4.89M | 0.11% |
100,000
+50,000
| +100% | +$2.45M |
|
|
SGEN
41
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.72M | 0.1% |
+75,000
| New | +$4.72M |
|
42
Larimar Therapeutics
LRMR
$337M
| $4.66M | 0.1% |
83,333
+41,666
| +100% | +$2.33M |
|
|
JUNO
43
DELISTED
Juno Therapeutics, Inc.
JUNO
| $4.44M | 0.1% |
200,000
| – | – |
|
44
Lineage Cell Therapeutics
LCTX
$281M
| $4.42M | 0.1% |
1,465,383
| – | – |
|
45
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.2M | 0.09% |
+500,000
| New | +$4.2M |
|
|
CCXI
46
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.98M | 0.09% |
546,278
| – | – |
|
|
AIMT
47
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $3.95M | 0.09% |
181,600
+100,000
| +123% | +$2.17M |
|
|
SIOX
48
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $3.74M | 0.08% |
31,250
-6,250
| -17% | -$747K |
|
49
Intel
INTC
$105B
| $3.61M | 0.08% |
+100,000
| New | +$3.61M |
|
|
CLLS
50
Cellectis
CLLS
$260M
| $3.6M | 0.08% |
150,000
| – | – |
|